Catalent Biologics Content

1. Data-Driven Manufacturing And Case Management In Autologous Cell Therapy 3/25/2026

   Explore how data-driven manufacturing and end-to-end supply chain orchestration can help cell therapy developers overcome manufacturing challenges, reduce costs, and scale programs more effectively.

2. Catalent Capabilities Update March 2026: Analytical Services 3/24/2026

   A biologics analytics leader showcases development, testing, and characterization capabilities, emphasizing quality, regulatory compliance, and integrated support from discovery to commercialization.

3. Critical Path For Gene Therapy: AAV Analytical Lifecycle Considerations 12/2/2025

   Explore considerations for phase-appropriate AAV characterization and release activities from pre-clinical to late-phase products. Review validation challenges and paths for maturation of analytics.

4. Advanced iPSC Workflows: Accelerating Cell Therapy Development 9/30/2025

   Beyond offering our GMP-compliant iPS cells, we develop superior workflows for gene editing and differentiation to provide competitive platforms to our partners and accelerate their therapeutic programs.

5. UpTempo℠: Seamless Transitions From Bench To CGT Applications 6/19/2025

   Accelerate cell and gene therapy development with high-yield, regulatory-compliant plasmid DNA manufacturing that shortens timelines, minimizes risks, and streamlines your supply chain.

6. Quantifying Cell Response With Duplex RT-qPCR

   Discover a new potency bioassay using RT-qPCR to assess relative transcription activity, and learn more about the advantages and limitations of transcriptional assays versus reporter gene assays.